What is the process involved in taking a new drug from the laboratory to market? What are the barriers and logistical challenges along the way? Join us and take this free, pre-recorded on-demand session on Drug Development Fundamentals. In this session, Dione Kobayashi, PhD, Head of Therapeutics and Operating Partner with Amplify, will discuss the factors driving successful drug development and outline approaches that may be applied in the academic setting.
Dione Kobayashi is Head of Therapeutics and Operating Partner with Amplify. Previously, Dione was Vice President of Preclinical Translation at Cydan Development where she managed diligence opportunities, led scientific projects, and operated companies before advancing them to Series A launch. Prior to Cydan, Dione held roles as a Director at the neurodegeneration startups Alector and Annexon, and the venture philanthropy-oriented Spinal Muscular Atrophy Foundation. Dione received an undergraduate degree from MIT, a master’s degree from the University of Hawai’i at Mānoa, and her Ph.D. in neuroscience from the University of Edinburgh. Dione has launched or cofounded multiple companies in the CNS, gene therapy, and rare disease space, and has raised fund for seeds, Series A, and a Fund.